Interrogate the SARS-CoV-2 genome with NGS

Form submitted successfully. Thank you. You may access the webinars below.


COVID and beyond: NGS applications for public health surveillance, epidemiology, and emerging pathogen identification

WE47722-speaker-EugeneYeboah

Eugene Yeboah
Sr. Scientist, The Association of Public Health Laboratories


Targeted sequencing of large and small viruses

WE47722-speaker-DirkDittmer

Dr. Dirk Dittmer
Director, Vironomics Core, The University of North Carolina, Chapel Hill


Development and application of environmental genomics in ecological environment monitoring and management

WE47722-speaker-ZhangXiaowei

Dr. Zhang Xiaowei
Professor, Nanjing University, Nanjing, Jiangsu, China


Ion AmpliSeq White Glove Service: Custom NGS solutions for infectious disease research

WE47722-speaker-GiorgioPea

Dr. Giorgio Pea
Product Manager, Thermo Fisher Scientific


Ecogenomics: whole-genome SARS-CoV-2 wastewater AmpliSeq multi-sample analysis

WE46910-Speaker-RogerLevesque

Roger Levesque, Ph.D.
Founder, Integrative and Systems Biology Institute, Université Laval, Québec, Canada


SARS-CoV-2 testing and variants' surveillance in the Indian Scenario

WE46910-Speaker-PotdarVarshaAtul

Potdar Varsha Atul, Ph.D., MSc
Head National Influenza Centre, ICMR National Institute of Virology, Pune, India


The utility of SARS-CoV-2 genome sequencing on the Ion Torrent Genexus Platform

WE46910-Speaker-SixtoLeal

Sixto M. Leal Jr., MD, PhD
Director, Clinical Microbiology, The University of Alabama at Birmingham


Advances in Next-Generation Sequencing for the identification and characterization of viral pathogens

WE46099-Speaker-RobSchuurman

Rob Schuurman, PhD
Head of Molecular Diagnostics, Department of Virology, University Medical Centre Utrecht, Netherlands


Syndromic testing by targeted next-generation sequencing: Detection of infectious diseases of animals from clinical samples

WE46099-Speaker-RebeccaWilkes

Rebecca Wilkes, DVM, PhD
Associate Professor, Molecular Diagnostics; Section Head for Molecular and Virology; Purdue University


Emergence and spread of variants of SARS-CoV-2 in SA and Africa

WE46099-Speaker-TuliodeOliveira

Prof. Tulio de Oliveira, PhD
Professor of Bioinformatics: School for Data Science and Computational Thinking; Faculty of Science and Faculty of Medicine and Health Sciences, Stellenbosch University, South Africa


Mako Medical: Rapidly Expanding SARS-CoV-2 Sequencing Capacity to Support CDC Efforts

WE46099-Speaker-MattTugwell

Matt Tugwell
Director, Genomics, Mako Medical, USA


SARS-CoV-2 complete genome sequencing research from the Japan Osaka region using Ion Torrent Genexus Integrated Sequencer

WE46099-Speaker-NarumiUeda

Dr. Narumi Ueda
Assistant Professor, Department of Orthopaedic Surgery, Kansai Medical University Medical Center, Japan


SARS-CoV-2 testing and sequencing for international arrivals reveals significant cross border transmission of high-risk variants into the United Kingdom

WE45546-speaker-MarcoLoddo

Dr. Marco Loddo
Co-Founder and Scientific Director, Oncologica UK Ltd, UK


Pivoting from cancer to COVID-19 in a global pandemic

WE45546-speaker-PaulHofman

Prof. Dr. Paul Hofman
Head of the Laboratory of Clinical and Experimental Pathology at the University Hospital Nice, France


Implementation of SARS-CoV2 NGS analysis at Amsterdam UMC

WE45546-speaker-MarcelJonges

Dr. Ir. Marcel Jonges
Laboratory Head of Medical Microbiology and Infection Prevention, Amsterdam UMC, The Netherlands


SARS-CoV-2 variants: Role of real-time genomic sequencing in COVID-19 response

WF23567-speaker-barbara-bartolini

Dr. Barbara Bartolini
Senior Scientist at Microbiology Laboratory and Infectious Diseases Biorepository at the National Institute for Infectious Diseases "L. Spallanzani" (INMI), Rome, Italy


One year of SARS-CoV-2 surveillance in wastewater

WF23567-speaker-ing-shelesh-agrawal

Dr. Ing. Shelesh Agrawal
Microbiology Group Leader, Technical University of Darmstadt, Institut IWAR, Germany


Featured Ion Torrent NGS solutions for SARS-CoV-2 research

Rapid sequencing of the complete SARS-CoV-2 genome for epidemiology research

The Ion AmpliSeq SARS-CoV-2 Research Panel for the Genexus Integrated Sequencer enables complete viral genome sequencing and variant detection of SARS-CoV-2 with >99% coverage. Rapidly go from nucleic acid to variant report in under a single day with minimal hands-on time. Bring simple, practical NGS to your lab. Learn more

Request virtual demo of the Ion Torrent Genexus System

Comprehensive, end-to-end immunology solutions for vaccine research

Ion Torrent targeted NGS provides a multi-dimensional approach to repertoire sequencing and immune response, enabling a deeper understanding of the adaptive immune system and its role in human health and response to infection and vaccines. Each assay is part of an end-to-end workflow that includes simple data analysis tools so you can focus on the biological meaning of your data.

Discover our solutions for vaccine research and study additional factors that influence host genetics and immune pathways:

  • TCR and BCR sequencing
  • Microbiome analysis
  • Gene expression and transcriptome analysis